Effects of a single dose of psilocybin on behaviour, brain 5-HT 2A receptor occupancy and gene expression in the pig Read More > December 4, 2020
Modulation of the functional connectome in major depressive disorder by ketamine therapy Read More > December 3, 2020
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence Read More > December 3, 2020
The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action Read More > December 3, 2020
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies Read More > December 1, 2020
Psychedelic-assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports Read More > December 1, 2020
Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison Read More > December 1, 2020
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System Read More > December 1, 2020
Corticosterone as a Potential Confounding Factor in Delineating Mechanisms Underlying Ketamine’s Rapid Antidepressant Actions Read More > November 30, 2020
